Peer review reports
From: Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer
Original Submission | ||
---|---|---|
19 Jul 2023 | Submitted | Original manuscript |
12 Aug 2023 | Reviewed | Reviewer Report - Mark S. Soloway |
14 Aug 2023 | Reviewed | Reviewer Report - Kim Moretti |
24 Aug 2023 | Author responded | Author comments - Giorgio Gandaglia |
Resubmission - Version 2 | ||
24 Aug 2023 | Submitted | Manuscript version 2 |
Publishing | ||
3 Sep 2023 | Editorially accepted | |
30 Sep 2023 | Article published | 10.1186/s12894-023-01315-5 |